Skip to main content

Advertisement

Log in

Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Background

We previously found a higher incidence of circulating tumour cells (CTCs) in women with metastatic breast cancer compared to early disease. In this study, we present follow-up data to explore the prognostic significance of these findings.

Methods

CTCs were quantified by immunostaining and direct visualization after centrifugation and filtration enrichment of peripheral blood from 131 patients. Time to progression (TTP) and overall survival (OS) were defined as interval from first blood sampling to first documented disease progression, or death respectively. Lifetime data was analysed using Kaplan–Meier method, log-rank test and Cox proportional hazards model.

Results

Follow-up data is available for 123 patients. In early disease, median CTC≥4 best distinguished patients with shorter TTP (p=0.05, log-rank test). In univariate analysis, tumour size, grade, lymphovascular invasion (LVI) and receptor status significantly related to TTP but none of the covariates related to OS. In multivariate analysis, T stage was the only independent predictor of TTP. In metastatic disease, median CTC≥13 optimally identified patients with shorter TTP (p=0.01). In univariate analysis, median CTC level ≥13 and prior lines of chemotherapy predicted for TTP while in multivariate analysis, median CTC level ≥13 was the only significant independent prognostic factor (p=0.02). No relationship between CTC level and OS was found in this subgroup.

Conclusion

Median CTC level determined in the course of treatment predicts for TTP in metastatic breast cancer. In early breast cancer, an association was found between CTC level and TTP although this did not reach statistical significance (p=0.05).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Asworth TR, A case of cancer in which cells similar to those in tumors were seen in the blood after death Aust Med J 14: 146, 1869

    Google Scholar 

  2. Chritopherson WM, Cancer cells in the peripheral blood: a second look Acta Cytol 86:169–174, 1965

    Google Scholar 

  3. Redding WH, Coombes RC, Monaghan P, Clink HM, Imrie SF, Dearnaley DP, Ormerod MG, Sloane JP, Gazet JC, Powles TJ, Detection of micrometastases in patients with primary breast cancer Lancet 2: 1271–1274, 1983

    PubMed  CAS  Google Scholar 

  4. Stahel RA, Mabry M, Skarin AT, Speak J, Bernal SD, Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody J Clin Oncol 3: 455–461, 1985

    PubMed  CAS  Google Scholar 

  5. Moss TJ, Sanders DG, Detection of neuroblastoma cells in blood J Clin Oncol 8: 736–740, 1990

    PubMed  CAS  Google Scholar 

  6. Lee MS, Chang KS, Cabanillas F, Freireich EJ, Trujillo JM, Stass SA, Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification Science 237:175–178, 1987

    Article  PubMed  CAS  Google Scholar 

  7. Cave H, Guidal C, Rohrlich P, Delfau MH, Broyart A, Lescoeur B, Rahimy C, Fenneteau O, Monplaisir N, d’Auriol L, Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes Blood 83:1892–1902, 1994

    PubMed  CAS  Google Scholar 

  8. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M, Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction J Clin Oncol 12: 725–729, 1994

    PubMed  CAS  Google Scholar 

  9. Campana D, Pui CH, Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance Blood 85:1416–1434, 1995

    PubMed  CAS  Google Scholar 

  10. Miyajima Y, Kato K, Numata S, Kudo K, Horibe K, Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA Cancer 75: 2757–2761, 1995

    Article  PubMed  CAS  Google Scholar 

  11. Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, Nakao K, Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood Cancer 75: 2214–2219, 1995

    Article  PubMed  CAS  Google Scholar 

  12. Ring A, Smith IE, Dowsett M, Circulating tumour cells in breast cancer Lancet Oncol 5:79–88, 2004

    Article  PubMed  Google Scholar 

  13. Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Kouroussis Ch, Apostolaki S, Malamos N, Kakolyris S, Kotsakis A, Xenidis N, Reppa D, Georgoulias V, Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance J Clin Oncol 20: 3404–3412, 2002

    Article  PubMed  CAS  Google Scholar 

  14. Smith BM, Slade MJ, English J, Graham H, Luchtenborg M, Sinnett HD, Cross NC, Coombes RC, Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques J Clin Oncol 18:1432–1439, 2000

    PubMed  CAS  Google Scholar 

  15. Weigelt B, Bosma AJ, Hart AA, Rodenhuis S, van ‘t Veer LJ, Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients Br J Cancer 88:1091–1094, 2003

    Article  PubMed  CAS  Google Scholar 

  16. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW, Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases Clin Cancer Res 10:6897–6904, 2004

    Article  PubMed  Google Scholar 

  17. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF, Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351:781–791, 2004

    Article  PubMed  CAS  Google Scholar 

  18. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW, Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer J Clin Oncol 23:1420–1430, 2005

    Article  PubMed  Google Scholar 

  19. Kahn HJ, Presta A, Yang LY, Blondal J, Trudeau M, Lickley L, Holloway C, McCready DR, Maclean D, Marks A, Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage Breast Cancer Res Treat 86: 237–247, 2004

    Article  PubMed  Google Scholar 

  20. Kahn HJ, Yang LY, Blondal J, Lickley L, Holloway C, Hanna W, Narod S, McCready DR, Seth A, Marks A, RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters Breast Cancer Res Treat 60: 143–151, 2000

    Article  PubMed  CAS  Google Scholar 

  21. Terstappen LW, Rao C, Gross S, Weiss AJ, Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast Int J Oncol 17: 573–578, 2000

    PubMed  CAS  Google Scholar 

  22. Pachmann K, Clement JH, Hoeffken K, Schneider C, Lobodasch K, Camara O, Pachmann U: Quantitative monitoring of circulating epithelial cells for individual therapy control in lung and breast cancer during neoadjuvant treatment, surgery and adjuvant chemotherapy [abstract]. Am Soc Clin Oncol Abstract 631, 2005

  23. Almokadem S, Leitzel K, Harvey HA, Bannon E, Ali SM, Miller C, Repollet M, Allard WJ, Terstappen L, Lipton A: Circulating tumor cells in adjuvant breast cancer patients [abstract]. Am Soc Clin Oncol Abstract 667, 2005

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nan Soon Wong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong, N., Kahn, H., Zhang, L. et al. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients. Breast Cancer Res Treat 99, 63–69 (2006). https://doi.org/10.1007/s10549-006-9181-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-006-9181-4

Keywords

Navigation